PofoliaShared via Pofolia

PLoS ONE· 2026Q1

Association of admission aggregate index of systemic inflammation with lower-extremity deep vein thrombosis after severe trauma

Qichang Sun, Donghui Bian

Short summary

An aggregate index of systemic inflammation (AISI), calculated from platelet, neutrophil, monocyte, and lymphocyte counts at admission, independently predicts lower-extremity deep vein thrombosis (LEDVT) in severe trauma patients, increasing risk prediction accuracy by 9.5% when added to clinical variables.

AI-generated from the title and abstract; the full text is not read.

Key points

  • The aggregate index of systemic inflammation (AISI), based on platelet, neutrophil, monocyte, and lymphocyte counts, is associated with ultrasound-confirmed in-hospital LEDVT after severe trauma.
  • Each 1-SD increase in log-transformed AISI was associated with LEDVT (OR, 1.86; P = 0.002) after adjusting for clinical variables and coagulation markers.
  • Adding AISI to clinical variables improved the area under the receiver operating characteristic curve (AUC) for LEDVT prediction from 0.619 to 0.714 (AUC difference, 0.095; P = 0.009).
  • Internal validation showed promising results, but prospective external validation is required.

AI-generated from the title and abstract; the full text is not read.

Abstract

Early identification of patients at risk for lower-extremity deep vein thrombosis (LEDVT) after severe trauma remains difficult. This retrospective cohort study evaluated whether admission aggregate index of systemic inflammation (AISI), derived from platelet, neutrophil, monocyte, and lymphocyte counts, was associated with ultrasound-confirmed in-hospital LEDVT detected before the earlier of discharge or post-injury day 30 and whether it improved risk stratification. Among 223 adults with an Injury Severity Score of 16 or higher and evaluable bilateral lower-extremity ultrasonography, 93 (41.7%) had LEDVT. Each 1-SD increase in log-transformed AISI was associated with LEDVT after adjustment for age, sex, Injury Severity Score, Glasgow Coma Scale score, and shock index (odds ratio [OR], 2.07; 95% CI, 1.47–2.91; P < 0.001) and after additional adjustment for D-dimer, fibrin/fibrinogen degradation products, prothrombin time, activated partial thromboplastin time, and fibrinogen (OR, 1.86; 95% CI, 1.26–2.73; P = 0.002). Adding AISI to clinical variables increased the area under the receiver operating characteristic curve (AUC) from 0.619 to 0.714 (AUC difference, 0.095; bootstrap 95% CI, 0.023 to 0.168; P = 0.009). After coagulation markers were included, the AUC difference was smaller and uncertain (0.018; 95% CI, −0.010 to 0.046; P = 0.166), although the Brier score improved by 0.014 (P = 0.020). For Model 4, bootstrap-corrected and repeated-cross-validation AUCs were 0.797 and 0.790, and calibration slopes were 0.831 and 0.773, respectively. With 93 events and 11 candidate parameters, these internally validated results indicate shrinkage and require prospective external validation; AISI should be interpreted as a complementary admission marker.

The authors' abstract, as published at the source. PLoS ONE, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Internal Medicine

Internal MedicineMedicine